- Enters into a standstill agreement until May 6, 2025 in respect of pre-funded SPA - SAN DIEGO, CA, April 24, 2025 (GLOBE NEWSWIRE) -- RYVYL Inc. ( RVYL) ("
First contract has onboarded over 1,000 accounts with 50,000+ more accounts expected in 2025 Second contract to onboard over 900,000 accounts over a 12-month p
SAN DIEGO, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP is conducting a thorough investigation into possible violations of securities laws by specifi
- Expects 2025 gross margin to expand to mid-40s percentage - SAN DIEGO, CA, Feb. 25, 2025 (GLOBE NEWSWIRE) -- RYVYL Inc. ( RVYL) ("RYVYL" or the "Company"),
SAN DIEGO, CA, Jan. 24, 2025 (GLOBE NEWSWIRE) -- RYVYL Inc. ( RVYL) ("RYVYL" or the "Company"), a leading innovator of payment transaction solutions leveragin
RYVYL Executes Repurchase and Repayment Agreement with Securityholder to Retire All Outstanding Series B Convertible Preferred Stock and Outstanding Balance of 8% Senior Convertible Note
SAN DIEGO, CA, Nov. 20, 2024 (GLOBE NEWSWIRE) -- RYVYL Inc. ( RVYL) ("RYVYL" or the "Company"), a leading innovator of payment transaction solutions leveragin
SAN DIEGO, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP is conducting a thorough investigation into possible violations of securities laws by...
We recently published a list of 7 Most Undervalued Blockchain Stocks To Buy According To Analysts. In this article, we are going to take a look at where Ryvyl Inc.
Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares climbed 118.4% to close at $74.59 on Friday after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per share.